Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

A female runner's hair loss was caused by stress from surgery and recovery, but her hair returned to normal in 5 months.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Collagen supplements may improve skin, joints, and recovery, especially with added nutrients.

A drug helped quickly reduce a movement disorder, experts debated the severity of Raynaud phenomenon, and rapid weight loss was linked to temporary hair loss with good recovery.

Tight junctions help control skin shedding and may be targets for treating certain skin conditions.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

Homeopathy helped a man regrow hair and feel better from total hair loss.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Cuticapil Stem Hair Serum improves hair growth and reduces shedding when added to minoxidil.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

The new hair restoration technique shows promise for quick, appealing results with minimal recovery time.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

The symposium concluded that understanding how different species repair tissue and how this changes with age can help advance regenerative medicine.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.